In a complementary approach, shRNAs targeting the kinase domain of TYK2-mediated downregulation of TYK2, as confirmed by western blot, and each led to growth reduction and apoptosis induction in both ALCL cell lines tested (Fig. 2b, Suppl. Here, TYK2 is linked to anaplastic large cell lymphoma.